GLAUKOS CORPORATION

Lobbying for GLAUKOS CORPORATION · Research and product development

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · $50,000.00 expenses · posted Jul 21, 2025

Bills named in this filing 3

Lobbying activity 3

Taxation/Internal Revenue Code

Corporate tax issues

Medicare/Medicaid

H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025

Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.